<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: E8(R1) General Considerations for Clinical Studies; International Council for Harmonisation; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: E8(R1) General Considerations for Clinical Studies; International Council for Harmonisation; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2022-04-11 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "E8(R1) General Considerations for Clinical Studies." The guidance was prepared under the auspices of the International Council for Harmonisation (ICH), formerly the International Conference on Harmonisation. The guidance describes internationally accepted principles and practices for the design and conduct of clinical studies of drug and biological products. In addition, the...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-07690</p>
    <p><strong>Publication Date:</strong> 2022-04-11</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/04/11/2022-07690/e8r1-general-considerations-for-clinical-studies-international-council-for-harmonisation-guidance">https://www.federalregister.gov/documents/2022/04/11/2022-07690/e8r1-general-considerations-for-clinical-studies-international-council-for-harmonisation-guidance</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-07690</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
